Intervention

Fimasartan

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 30 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials30

Recruiting0

Common conditions13

Lead sponsors shown7

Clinical trials

30 shown

A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary HypercholesterolemiaNCT05930028 · 2023-07-13

Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and HypertensionNCT05173025 · 2018-01-01

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male SubjectsNCT02704702 · 2016-03-01

A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination TabletNCT02566187 · 2015-08-01

Fimasartan Achieving SBP Target (FAST) StudyNCT02495324 · 2015-06-01

Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic PatientsNCT02312375 · 2015-03-01

Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male VolunteersNCT02397590 · 2015-03-01

Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male SubjectsNCT02397538 · 2015-02-01

Comparison of Blood Pressure Lowering Effect Between Fimasartan and LosartanNCT02958631 · 2014-11-01

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/HydrochlorothiazideNCT02222480 · 2014-10-01

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and DyslipidemiaNCT02166814 · 2014-08-01

to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and RosuvastatinNCT02205190 · 2014-07-01

To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual TabletsNCT02205151 · 2014-07-01

Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial HypertensionNCT02248961 · 2014-05-01

Fimasartan/Amlodipine Combination Phase IIINCT02152306 · 2014-04-01

To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and RosuvastatinNCT01921946 · 2013-08-01

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential HypertensionNCT01878201 · 2013-05-01

Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential HypertensionNCT02466490 · 2013-04-01

Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive PatientsNCT01736488 · 2012-10-01

A Trial of Fimasartan for Early Diastolic Heart FailureNCT01691118 · 2012-09-01

Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECGNCT03219632 · 2012-06-05

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential HypertensionNCT01672476 · 2012-04-01

Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSionNCT02022774 · 2012-04-01

A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapyNCT01258673 · 2010-11-01

A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersNCT00991705 · 2009-07-01

A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male VolunteersNCT00938197 · 2009-06-01

A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male VolunteersNCT00923533 · 2009-03-01

Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male VolunteersNCT00937534 · 2009-01-01

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension PatientsNCT00922480 · 2008-12-01

Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension PatientsNCT00923611 · 2007-09-01

Common conditions

Hypertension18 Essential Hypertension8 Arterial Hypertension1 Atherosclerosis1 Diabetes Mellitus1 Diabetes Mellitus, Type 21 Essential Hypertension, Dyslipidemia1 Essential,Hypertension1 Hyperlipidemia1 Hypertension, Essential1 Left Ventricular Hypertrophy1 Primary Hypercholesterolemia1 Renin Hypertension1

Leading sponsors

Boryung Pharmaceutical Co., Ltd 23 Seoul National University Bundang Hospital 2 Asan Medical Center 1 Chuncheon Sacred Heart Hospital 1 R-Pharm 1 Seoul National University Hospital 1 Stendhal Americas, S.A. 1

Trial status mix

COMPLETED28

UNKNOWN2

Phase mix

PHASE111

PHASE38

PHASE45

PHASE23

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.